Montanaro Asset Management Ltd decreased its holdings in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 13.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 775 shares of the biotechnology company’s stock after selling 125 shares during the quarter. Montanaro Asset Management Ltd’s holdings in Axon Enterprise were worth $310,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Blue Trust Inc. raised its stake in Axon Enterprise by 987.5% in the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after acquiring an additional 79 shares during the last quarter. Quent Capital LLC increased its holdings in shares of Axon Enterprise by 1,875.0% in the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after purchasing an additional 75 shares during the period. Asset Dedication LLC purchased a new position in shares of Axon Enterprise in the second quarter worth about $47,000. Friedenthal Financial acquired a new stake in shares of Axon Enterprise during the third quarter worth about $51,000. Finally, Cullen Frost Bankers Inc. purchased a new stake in Axon Enterprise in the second quarter valued at approximately $59,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on the stock. JMP Securities raised their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. Northland Securities boosted their target price on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a research report on Thursday, August 8th. Craig Hallum upped their price target on shares of Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a report on Wednesday, August 7th. Robert W. Baird lifted their price objective on Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Finally, Jefferies Financial Group assumed coverage on Axon Enterprise in a research note on Wednesday, July 17th. They issued a “buy” rating and a $385.00 target price on the stock. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $412.42.
Insider Buying and Selling at Axon Enterprise
In other news, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $437.98, for a total value of $437,980.00. Following the completion of the sale, the director now owns 26,259 shares of the company’s stock, valued at $11,500,916.82. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, Director Michael Garnreiter sold 1,000 shares of the company’s stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $437.98, for a total value of $437,980.00. Following the transaction, the director now owns 26,259 shares of the company’s stock, valued at $11,500,916.82. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Patrick W. Smith sold 80,300 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $371.78, for a total value of $29,853,934.00. Following the transaction, the chief executive officer now owns 3,015,366 shares of the company’s stock, valued at approximately $1,121,052,771.48. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 369,172 shares of company stock worth $136,270,842 in the last ninety days. 6.10% of the stock is owned by insiders.
Axon Enterprise Trading Up 28.7 %
Shares of AXON opened at $603.18 on Friday. Axon Enterprise, Inc. has a 12-month low of $212.88 and a 12-month high of $611.88. The firm has a market capitalization of $45.58 billion, a P/E ratio of 155.86, a P/E/G ratio of 15.15 and a beta of 0.94. The firm has a 50-day moving average price of $414.16 and a 200 day moving average price of $347.27. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Further Reading
- Five stocks we like better than Axon Enterprise
- How to Read Stock Charts for Beginners
- California Resources Stock Could Be a Huge Long-Term Winner
- Why is the Ex-Dividend Date Significant to Investors?
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- Canadian Penny Stocks: Can They Make You Rich?
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.